BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2025-12-12
• Last 15 days FTD volume: HK$0.38 M
• Last 3 months FTD volume: HK$0.71 M
• Last 12 months FTD volume: HK$4.9 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	HK$4.86 M	HK$20.66 M	🇺🇸 USA
Sarepta Therapeutics SRPT	HK$2.06 M	HK$19.19 M	🇺🇸 USA
NanoViricides NNVC	HK$1.64 M	HK$6.3 M	🇺🇸 USA
Novavax NVAX	HK$13.09 M	HK$57.41 M	🇺🇸 USA
Gilead Sciences GILD	HK$35.08 M	HK$0.24 B	🇺🇸 USA
Celldex Therapeutics CLDX	HK$6.65 M	HK$12.24 M	🇺🇸 USA
GlaxoSmithKline GSK	HK$47.68 M	HK$0.40 B	🇬🇧 UK
Emergent BioSolutions EBS	HK$1.18 M	HK$4.6 M	🇺🇸 USA
Cel-Sci CVM	N/A	HK$0.76 M	🇺🇸 USA